RACIAL AND GENDER DISPARITIES, AND IMPACT OF ANTIFIBROTIC THEPARY ON HOSPITAL OUTCOMES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

被引：0
|
作者：
Ghimire, Prabina
Gupta, Sushan
Thameem, Danish
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.06.1913
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：3193A / 3193A
页数：1
相关论文
共 50 条
  • [1] Racial and Ethnic Disparities in Antifibrotic Therapy in Idiopathic Pulmonary Fibrosis
    Fares, J.
    Zhao, J.
    George, G.
    Maheu, A.
    Loizidis, G.
    Roman, J.
    Kramer, D. R.
    Li, M.
    Summer, R. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [2] Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis
    Zhao, Joy
    Fares, Joseph
    George, Gautam
    Maheu, Arlene
    Loizidis, Giorgos
    Roman, Jesse
    Kramer, Daniel
    Li, Michael
    Summer, Ross
    RESPIROLOGY, 2023, 28 (11) : 1036 - 1042
  • [3] Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
    Bryan T. Kelly
    Viengneesee Thao
    Timothy M. Dempsey
    Lindsey R. Sangaralingham
    Stephanie R. Payne
    Taylor T. Teague
    Teng Moua
    Nilay D. Shah
    Andrew H. Limper
    BMC Pulmonary Medicine, 21
  • [4] Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
    Kelly, Bryan T.
    Thao, Viengneesee
    Dempsey, Timothy M.
    Sangaralingham, Lindsey R.
    Payne, Stephanie R.
    Teague, Taylor T.
    Moua, Teng
    Shah, Nilay D.
    Limper, Andrew H.
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [5] The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
    Kette, Stefano
    Reccardini, Nicolo
    Salton, Francesco
    Confalonieri, Paola
    Andrisano, Alessia
    Chianese, Maria
    De Nes, Anna
    Maggisano, Marta
    Galantino, Alessandra
    Nicolosi, Salvatore
    Mari, Marco
    Salotti, Andrea
    Angoni, Darina
    Chernovsky, Maria
    Hughes, Michael
    Confalonieri, Marco
    Mondini, Lucrezia
    Ruaro, Barbara
    PHARMACEUTICALS, 2025, 18 (03)
  • [6] Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary Fibrosis
    Kaul, Bhavika
    Lee, Joyce S.
    Petersen, Laura A.
    McCulloch, Charles
    Rosas, Ivan O.
    Bandi, Venkata D.
    Zhang, Ning
    DeDent, Alison M.
    Collard, Harold R.
    Whooley, Mary A.
    CHEST, 2023, 164 (02) : 441 - 449
  • [7] Outcomes of Antifibrotic Treatment in Idiopathic Pulmonary Fibrosis (IPF) Patients with Circulating Autoantibodies
    Smith, A.
    Ding, G.
    Kropski, J.
    Mason, W.
    Lancaster, L. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [8] Impact of reduction in antifibrotic treatment on mortality in idiopathic pulmonary fibrosis
    Porse, Simon
    Hoyer, Nils
    Shaker, Saher B.
    RESPIRATORY MEDICINE, 2022, 204
  • [9] Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives
    Graney, Bridget A.
    Lee, Joyce S.
    PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 321 - 328
  • [10] Antifibrotic choice in idiopathic pulmonary fibrosis
    Hayton, Conal
    Morris, Helen
    Marshall, Tracey
    Zakis, Katie
    Garfoot, Theresa
    Ortega, Pilar Rivera
    Greaves, Melanie
    Leonard, Colm
    Chaudhuri, Nazia
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345